I. Interindividual and regional relationship between cerebral blood flow and glucose metabolism in the resting brain. Studies of the resting brain measurements of cerebral blood flow (CBF) show large interindividual and regional variability, but the metabolic basis of this variability is not fully established. The aim of the present study was to reassess regional and interindividual relationships between cerebral perfusion and glucose metabolism in the resting brain. Regional quantitative measurements of CBF and cerebral metabolic rate of glucose (CMRglc) were obtained in 24 healthy young men using dynamic [ 15 O]H2O and [ 18 F]fluorodeoxyglucose positron emission tomography (PET). Magnetic resonance imaging measurements of global oxygen extraction fraction (gOEF) and metabolic rate of oxygen (gCMR O 2 ) were obtained by combined susceptometry-based sagittal sinus oximetry and phase contrast mapping. No significant interindividual associations between global CBF, global CMR glc, and gCMR O 2 were observed. Linear mixed-model analysis showed a highly significant association of CBF with CMR glc regionally. Compared with neocortex significantly higher CBF values than explained by CMRglc were demonstrated in infratentorial structures, thalami, and mesial temporal cortex, and lower values were found in the striatum and cerebral white matter. The present study shows that absolute quantitative global CBF measurements appear not to be a valid surrogate measure of global cerebral glucose or oxygen consumption, and further demonstrates regionally variable relationship between perfusion and glucose metabolism in the resting brain that could suggest regional differences in energy substrate metabolism.
INTRODUCTION
Most studies involving measurements of global cerebral blood flow (gCBF) have reported large interindividual variability of these measures. Among healthy subjects, values of gCBF may typically vary by a factor of 2 or more between the upper and lower limit of the normal range (9, 35, 42) . Also resting global values of cerebral metabolic rates of oxygen (gCMR O 2 ) and of glucose (gCMR glc ) show similar large variability among healthy subjects (9, 13, 35, 42) . Analyzing repeated measurements of gCBF and gCMR O 2 , previous studies have confirmed large interindividual variability of perfusion and metabolism that cannot be attributed to measurement imprecision (18, 35, 41) .
Classically, a close coupling of perfusion and metabolism is assumed, reflecting oxidative phosphorylation of glucose as the predominant source of energy production. Consequently, CBF is often considered an indirect measure of neuronal function and integrity (23) . This is supported by significant association of metabolism with regional CBF (rCBF) across different brain regions (9, 43) and with gCBF across varying states of consciousness (12) .
However, despite more than half a century of research, little is known about the interindividual relationship between perfusion and metabolism in the human brain, i.e., do interindividual differences in perfusion correspond to similar interindividual differences in glucose and oxygen metabolism? Studies applying the Kety-Schmidt technique, often considered the gold standard for studying human brain perfusion and metabolism, indicate a linear relationship between gCBF and global metabolism (31) , but as gCMR O 2 and gCMR glc is calculated from arteriovenous differences scaled by gCBF, correlations of gCBF with these measures will tend to be biased by the gCBF measurements. Using positron emission tomography (PET) CMR glc and CBF may be quantified by independent techniques. A recent PET study failed to confirm interindividual association of hemispheric CBF and CMR glc , but did show a positive correlation of hemisphere CBF with CMR O 2 (42) . Nevertheless, PET measurements of CMR O 2 were biased as calculation of CMR O 2 involved scaling of OEF by CBF (similar to most other PET approaches for measuring CMR O 2 ), and the study consequently does not lend firm evidence of a direct interindividual association of CBF with CMR O 2 .
Also at the intrasubject regional level, regionally variable rCBF/rCMR glc and rCMR O 2 /rCMR glc ratios have been reported (16, 50) . These observations contradict the classical notion of perfusion being adjusted to deliver the oxygen required for oxidative phosphorylation of glucose (and thus predicting a linear relationship between these measures in the resting brain), whereas such uncoupling is well described during functional activation (44) . As pointed out by others these observations may be the result of not analyzing absolute quantitative data (22) , and prior studies have in general not taken into account regionally variable differences between the kinetics of the glucose analog fluorodeoxyglucose (FDG) and glucose (15) .
Factors altering gCBF with no or minimal effects on oxygen metabolism, e.g., arterial blood gasses (31) and caffeine intake (40) altering vascular tone, may cause changes in global oxygen extraction fraction (gOEF) thereby altering the relationship between perfusion and metabolism, and in turn lead to apparent dissociation of perfusion and metabolism. Also variable oxygen transport capacity of blood (hemoglobin concentration) should be taken into account (20) .
In summary, it is not clear to what degree the observed gCBF and rCBF variability reflects underlying variability of cerebral glucose metabolism, and to what extent such associations or lack of associations may be attributed to physiological factors or methodological biases. To address these issues, we report on a study of same-day PET measurements of rCBF and rCMR glc and magnetic resonance imaging (MRI) measurements of gOEF and gCMR O 2 in a group of healthy young male volunteers using currently available PET and MRI techniques. The aims of the analysis were twofold: first, to reassess the interindividual association of global values of cerebral perfusion with glucose and oxygen metabolism using methodindependent techniques while taking into account interindividual variation in hemoglobin, arterial PCO 2 and plasmacaffeine levels; second, to investigate the regional relationship between perfusion and glucose when taking regional errors of glucose metabolism quantitation into account.
MATERIALS AND METHODS

Study participants.
Measurements were performed as part of a crossover study investigating the effects of erythropoietin on cerebral metabolism (51). Data from this study have also been used in previous publications (52, 53) . Participants were investigated on two study days after either active or placebo treatment separated by 4 wk to avoid carryover effects of the first period. Only data obtained after placebo treatment are included in the present analysis. A total of 24 healthy male volunteers (mean age 27 yr, range 18 -40 yr) participated. Women were not included in the study in order to avoid the potential influence of varying sex hormone levels on cerebral perfusion during the menstrual cycle (32) . The study was approved by the regional ethics committee (Scientific Ethics Committee of the Capital Region, H-4 -2012-167), following the standards of The National Committee on Health Research Ethics. The experiments were con-ducted in accordance with the Helsinki Declaration, and all participants gave written informed consent.
Experimental set-up. On the day of the experiment, the volunteers were instructed to fast for at least eight hours, but were allowed to drink water. To avoid the effects of caffeine abstinence (2) and to assess the influence of spontaneous caffeine levels on cerebral vasculature and perfusion, the volunteers were also allowed to consume tea/coffee as usual.
Initially, an arterial cannula was inserted in the radial artery of the nondominant arm, and a venous cannula was inserted in a cubital vein in the contralateral arm. First two sequential CBF measurements were performed, and subsequently (usually within 30 min after the last rCBF measurement) a dynamic [ 18 F]FDG scan was performed for measurement of rCMR glc. After the PET scans, the volunteers were allowed a light meal before being transported to the MRI facility. The MRI scan was performed usually within 3 h after the PET studies. For clarity, the prefixes PET, MRI, and PET-MRI are used in tables and figures when reporting parameters derived from PET, MRI, and combined PET and MRI, respectively.
PET measurements of cerebral blood flow. PET scans were performed on a High Resolution Research Tomograph (HRRT, Siemens, Knoxville, TX) brain PET scanner. Details of image acquisition, reconstruction and analysis have been reported previously (52, 53) . Initially a transmission scan used for attenuation correction was acquired. Approximately 800 MBq of 15 O2-radiolabeled water produced online was injected as a slow bolus at 16 ml/min via an Automatic Water Injection System (Scansys Laboratorieteknik, Vaerløse, Denmark). Emission scans were acquired in list-mode for 7 min (collected into dynamic frames of 1 ϫ 30 s, 18 ϫ 5 s, 9 ϫ 10 s, 10 ϫ 15 s, and 2 ϫ 30 s) and reconstructed into isotropic voxels of 1.2 mm using ordinary Poisson three-dimensional ordered-subset expectation maximization with point spread function modeling (3D OSEM-PSF, 16 subsets and 10 iterations) (21) with attenuation correction using the TXTV method and scatter correction. A 5-mm 3D Gaussian filter was applied to the reconstructed images. Two measurements were performed in each subject. At least 10 min passed between the beginning of the two measurements to allow for washout and decay of the isotope.
For kinetic modeling, arterial blood activity was sampled during the scans using an automatic blood sampling system (Allogg ABSS, Mariefred, Sweden) set to draw 8 ml/min. Parametric images were generated with the software PMOD 3.0 (PMOD Technologies, Zürich, Switzerland) using a 1-tissue-compartment model with correction for arterial blood volume (11, 38) . The arterial input function was corrected for delay and dispersion. The rCBF is reported as the unidirectional clearance of tracer from the blood to the tissue (K1) divided by 0.84 to correct for the limited extraction of water (19) . Average rCBF maps are shown in Fig. 1 .
PET measurements of cerebral metabolic rate of glucose. Dynamic FDG PET scans were performed on the Siemens Biograph mCT (Siemens Healthcare, Erlangen, Germany). First a low-dose CT scan was performed for attenuation correction. At the time of injection of 200 MBq [ 18 F]FDG in an antecubital vein (followed by 10 ml of saline flush), a 60-min dynamic emission list-mode acquisition was commenced. PET images were collected into dynamic frames of 6 ϫ 10 s, 2 ϫ 30 s, 3 ϫ 1 min, 2 ϫ 2.5 min, 2 ϫ 5 min, and 4 ϫ 10 min and reconstructed into isotropic voxels of 2 mm and using 3D OSEM (4 iterations, 24 subset) and applying a 4-mm Gaussian filter. All PET data were corrected for randoms, scatter, attenuation, and radioactive decay.
PET reconstruction filters and voxel dimensions were designed to match the final image resolution of rCBF and rCMRglc maps to~6.5 mm Full-Width-Half-Maximum (FWHM) when considering differences in scanner resolution and positron energy.
For kinetic modeling, arterial blood samples were drawn before injection of the tracer and corresponding to the end of each frame. Thirty-three samples were drawn using 1 ml heparinized vacuum collection tubes. Just before each sampling, a similar vial was used to rinse residual activity out of the catheter. Blood samples were immediately placed on ice water until separation of plasma by centrifuge (3,500 rpm, 7 min at 4°C) within 1 h, and radioactivity concentrations were measured in 0.3 ml of plasma using a Wizard Automatic Gamma Counter (PerkinElmer, Waltham, MA). Samples were consecutively measured for 1 min. At 30 min, a 2 ml blood sample was collected in vacuum tubes (containing Na-fluoride and K-oxalate) for determination of plasma glucose at the hospital laboratory.
Parametric rCMR glc maps were generated with PMOD 3.0 (PMOD Technologies, Zürich, Switzerland) using the Patlak graphical method (39) assuming a lumped constant of 0.65 (55) . Motion correction was applied to dynamic frames using the mean image from frames 16 -19 (5-8 min after injection) as a reference using motion correction supplied by PMOD software (rigid body, 6 parameters). Average rCMR glc maps are shown in Fig. 1 .
MRI measurements of oxygen metabolism. MR scans were performed on a 3-T Philips Achieva MRI scanner (Philips Medical Systems, Best, The Netherlands) using a 32-channel phase array head coil. Global OEF is calculated as:
and global CMR O 2 can be computed by Fick's principle:
where Sa O 2 and SV O 2 are the arterial and venous oxygen saturation, respectively, and C O 2 is the oxygen binding capacity (mmol/l) of arterial blood and equals the individual hemoglobin concentration.
The arterial saturation was measured by arterial blood sampling, and the venous saturation was measured in the sagittal sinus using MRI susceptometry-based oximetry (29) . Processing was performed using Matlab (Mathworks, Natick, MA) scripts developed in house. The procedures involved and the theoretical background have been reported in details previously (52) .
Phase maps were created with a dual-echo gradient-echo sequence (1 slice, FOV 224 ϫ 176 mm 2 , voxel size 0.5 ϫ 0.5 ϫ 0.5 mm 3 , TE1/TE2 ϭ 7.00/20.29 ms, flip angle 30°, 10 repeated measures), and modulus, real and imaginary complex values from both echoes were saved. The imaging slice was placed orthogonally to a segment of the sagittal sinus closely parallel to the B0-magnetic field. The angle between the segment and the B0-field was estimated from the venous angiogram and used in the calculation. The phase maps were corrected for low-frequency variation from magnetic field inhomogeneities by fitting a thin-plate spline (TPS) model to the brain tissue immediately surrounding the sagittal sinus (52) . From field inhomogeneity-corrected phase maps, venous oxygenation (SV O 2 ) was estimated from the phase difference between the phase value of the sagittal sinus and the surrounding tissue ( Fig. 1 ).
We assumed CMR O 2 to be constant between the PET and the MRI session, and to account for the influence gCBF changes by moving the subjects from PET to MRI on the calculated CMR O 2 value, gCBF was measured also during the MRI session by mean of blood flow measurements of the feeding arteries of the brain using phase-encoding technique. Based on a 2-D inflow angiogram, the measurement slice was placed orthogonal to the vertebral and internal carotid arteries (1 slice, FOV ϭ 240 ϫ 240 mm 2 , voxel size 0.75 ϫ 0.75 ϫ 8mm 3 , TE ϭ 7.33 ms, TR ϭ 27.63 ms, flip angle 10°, 10 repeated measurements, Venc ϭ 100 cm/s, total scan time 1.42 min). The total flow was calculated by measuring the mean velocity and the cross-sectional area of the feeding arteries using in-house software as previously described (53 Image analysis of parametric PET images. All parametric PET images were converted to NIfTI format and analyzed using SPM software version 12 (Statistical Parametric Mapping, https://www.fil. ion.ucl.ac.uk/spm). First, the two rCBF maps were averaged to produce a single rCBF map, and the parametric PET rCBF and rCMRglc maps were coregistered to the 3-D T1-weighted MRI scan (affine transformation, 12 parameters). The 3-D T1-weighted MRI was then warped to MNI-152 standard space using the SPM Normalize function (4), which involves a nonlinear warp to a MRI template, and the same transformation was then applied to the parametric maps. To minimize partial volume effects in regional analysis, no additional filtering was applied.
For regional analysis, volumes of interest (VOIs) were applied to the spatially normalized parametric maps using automatic anatomical PET, positron emission tomography; rCBF, regional cerebral blood flow; rCMRglc, regional cerebral metabolic rate of glucose (not adjusted for regional lumped constant).
labeling (WFU PickAtlas, http://fmri.wfubmc.edu/software/PickAtlas). To simplify the analysis and reporting, nonoverlapping VOIs were grouped by main brain structure types: neocortex (frontal, parietal, temporal, and occipital, calcarine and primary sensory-motor cortex), mesial temporal (amygdala, hippocampus, and parahippocampal gyrus), striatum (putamen and caudate nucleus), thalami, infratentorial structures (cerebellar cortex, midbrain, and pons) and white matter (centrum semiovale). For each VOI, the average of mean VOI values from the two hemispheres was used.
Identical intrasubject VOIs were used for all paired gCBF and gCMR glc measurements to avoid potential biases caused by withinregion tissue heterogeneity by matching tissue composition.
To account for the 12% lower lumped constant in infratentorial structures (15) , corrected VOI CMR glc values for cerebellum, pons, and midbrain were calculated by dividing standard CMRglc by 0.88. Both standard and corrected values are reported.
A whole brain mask including cerebral hemisphere, cerebellum, and brain stem was applied to obtain values of gCBF and gCMR glc. To ensure accuracy of VOI based analysis in standard space we additionally performed ROI based analysis of selected regions (frontal, parietal, thalamus, cerebellum, pons, and white matter) in native space with CBF and CMR glc maps superimposed on each subject's own 3-D T1 MRI scan. As the results from the analysis from native space did not differ from that in standard space, we concluded that the VOI-based analysis in standard space is valid.
CMR glc and CMR O 2 are reported in micromoles per 100 g per minute and CBF in milliliters per 100 g per minute assuming a tissue density of 1.05 g/ml (49) . The global oxygen-to-glucose index (gOGI) was calculated as gCMR O 2 ⁄gCMR glc .
Blood sampling. At the end of each PET CBF measurement and MRI gOEF measurement, arterial blood samples were drawn into a heparinized syringe and subsequently analyzed for gas tensions on the ABL 800 system (Radiometer, Copenhagen, Denmark).
Venous blood samples were drawn before the FDG scan for determination of hemoglobin. For determination of plasma caffeine a vacuum tube containing Ci-plasma was drawn at 30 min into the FDG scan. Analysis of plasma caffeine was performed using a highperformance liquid chromatography/tandem mass spectrometry method originally developed and validated for analysis of urine samples adapted to analysis of plasma as previously described (37) . Intra-and interassay CV are both Ͻ7%.
Statistics. Descriptive statistics were summarized as means Ϯ SD, except for caffeine, which was summarized by median and interquartile range due to having a skewed distribution.
To evaluate the influence of global covariates (arterial PCO 2, hemoglobin, or plasma caffeine) on gCBF, regression analyses of gCBF with each covariate in turn as explanatory variables were performed both unadjusted and adjusted for gCMR glc.
Regional differences in rCBF, rCMRglc, and rCBF/rCMRglc were assessed in a linear mixed model including subject as a random effect to account for repeated measurements. To account for variance inhomogeneity and the fact that some regions were more strongly correlated than others, P values and confidence intervals from the mixed model analyses were based on robust standard errors.
The crude association between regional rCMR glc, and rCBF was evaluated in scatterplots and by simple linear regression for each region in turn. To further assess the effect of covariates on regional CBF, a linear mixed model similar to the above was applied with rCBF as dependent variable and rCMR glc, brain region, and gOEF as fixed effects. To separate global and regional effects of rCMRglc on rCBF, both gCMRglc and the deviation of rCMRglc (⌬rCMRglc) from gCMRglc were entered as fixed effect.
Thus regional CBF in the jth region of the ith subject was expressed as
where and ε denote between-subject and within-subject residual error terms. The linear mixed model thus combines analysis of regional and interindividual effects in a single model. In the exploratory analysis we also performed standard multiple regression analysis of interindividual effects which yielded similar results as the linear mixed model. For the analysis of main brain structures neocortex was reference region, and for analysis of neocortical regions parietal cortex was reference region. Initial exploratory analysis further included hemoglobin, caffeine, and arterial PCO 2 as fixed effects, but hemoglobin did not influence gCBF, and gOEF was found to account for the effects of both caffeine and arterial PCO2. Also, as gCBF was associated with gOEF, but not with CMR O 2 (unless adjusted for gOEF), only gOEF was included in the model. Arterial PCO 2 was not different between the PET and MRI sessions (mean difference Ϫ0.12 Ϯ 0.42, P ϭ 0.16), and for simplicity the mean arterial PCO2 values from the PET session were used in the analysis.
Identical models replacing rCBF with rDO2 (regional cerebral delivery of oxygen, i.e., rCBF multiplied with the hemoglobin concentration and the arterial oxygen saturation) were also investigated.
Goodness of fit was evaluated by residual plots. Analyses were performed with SAS version 9.4 (SAS Institute, Cary, NC).
RESULTS
In one subject MRI data were not acquired due to technical problems of the MRI scanner. MRI oximetry measurements were discarded in two subjects due to poor data quality, and in one subject measurement of MRI oximetry was not included in the scan protocol.
Summary statistics of the PET and MRI experiments are presented in Table 1 .
Simple regression analysis of whole brain values showed a borderline significant interindividual inverse association of gCBF with both gOEF and with caffeine, but no associations of gCBF with gCMR glc , gCMR O 2 , or hemoglobin were observed ( Fig. 2 and Table 2 ). Global OEF was inversely associated with arterial PCO 2 (R 2 ϭ 0.23, P ϭ 0.03) and tended to be positively associated with plasma caffeine (R 2 ϭ 0.14, P ϭ 0.10). No significant associations of gCMR glc with gCMR O 2 (R 2 ϭ 0.05, P ϭ 0.35), gOEF (R 2 ϭ 0.01, P ϭ 0.68), plasma caffeine (R 2 ϭ 0.07, P ϭ 0.21), or arterial PCO 2 (R 2 Ͻ 0.01, P ϭ 0.87) were observed. Across all VOIs a highly significant, but apparently nonlinear, positive association of rCBF with rCMR glc was found ( Fig.  3 , Spearman's r ϭ 0.56 and P Ͻ 0.001), but for the individual VOIs, no significant interindividual association of rCBF with rCMR glc could be demonstrated (R 2 Ͻ 0.08 and P Ն 0.19 for all, except for amygdala where R 2 ϭ 0.14 and P ϭ 0.08). A substantial regional variation was found not only in rCBF and rCMR glc , but also regionally variable rCBF/rCMR glc and rDO 2 /rCMR glc ratios were demonstrated (Table 3) . Mixed model analysis (Table 4 ) confirmed highly significant regional effects on rCBF (overall P Ͻ 0.001) with relatively higher rCBF than predicted from rCMR glc in infratentorial structures, thalami and mesial temporal cortex compared with neocortex, and relatively lower rCBF in striatum and white matter. In the analysis of neocortical regions, relatively higher rCBF was found in calcarine cortex (6.44 [95% CI: 4.72, 8.12] ml·100 g Ϫ1 ·min Ϫ1 , P Ͻ 0.001) and to a lesser degree in frontal cortex (0.94 [95% CI:Ϫ0.21, 1.67] ml·100 g Ϫ1 ·min Ϫ1 , P ϭ 0.012) compared with parietal cortex. Lower values were found in non-mesial temporal cortex (Ϫ2.31 [95% CI: Ϫ3.43, Ϫ1.19] ml·100 g Ϫ1 ·min Ϫ1 , P ϭ 0.001). Mixed model analysis further confirmed an inverse association of rCBF with gOEF and the lack of association with gCMR glc . Similar findings were observed in analysis of rDO 2 .
DISCUSSION
The present study analyzed absolute quantitative measurements of cerebral perfusion and glucose metabolism. First of all, the analysis failed to confirm direct interindividual associ- ations of perfusion with quantitative measures of glucose metabolism or oxygen metabolism. Second, the analysis demonstrated highly significant regional differences in the relationship between perfusion and glucose consumption.
The lack of interindividual association of gCBF with gCMR glc is in line with a previous study analyzing hemispheric values of PET measurements of CBF, CMR glc , and CMR O 2 (42) , but unlike that study we could not demonstrate a direct univariate association of CBF with CMR O 2 when quantified independently. In the present study, we found that the between-subject dissociation of gCBF from gCMR glc could not be attributed to variable gOEF only. We found a borderline significant inverse association of gCBF with gOEF, and gOEF tended also to show the expected associations with arterial PCO 2 and plasma caffeine. This observation supports the concept of gOEF being altered during passive changes in gCBF to maintain a given gCMR O 2 (31) , but the between-subject correlation is probably less strong mainly due to interindividual variation in CMR O 2 . Large gOEF variability can also be estimated from measurements of jugular vein oxygenation obtained by catheterization (OEF range 0.29 -0.54) (8) . Previous PET studies have also reported interindividual variability of resting gOEF with CV in the order of 7-14% (9, 27) similar to the value of 12% in the present study, or even up to 18 -22% (22, 43) . This finding thus appears to confirm that variable gOEF may explain a substantial fraction of the observed gCBF variability (and vice versa).
We further showed lack of association of gCMR O 2 with gCMR glc , indicating interindividual variable stoichiometry and possibly variable contributions of other sources of ATP generation than oxidative phosphorylation of glucose. Although the brain ATP production predominantly relies on oxidative phosphorylation of glucose, aerobic glycolysis (glycolysis in the presence of oxygen) with lactate as the end product is believed to account for 10 -12% of cerebral glucose consumption globally, but only for less than 1% of total brain energy production (50) . This fraction may increase during activation (34, 36) , and decrease during sleep (7) . The OGI is often used as a measure of aerobic glycolysis and values below 6 indicate aerobic glycolysis. The population mean gOGI is slightly lower than the theoretical values of 6, and in agreement with oxidative phosphorylation of glucose as the main source of ATP production. We noted a relatively large interindividual variability of gOGI (range 4.1-7.7) that could simply reflect imprecision of both the numerator and the denominator of the fraction. Still, gOGI mean and standard deviation are very similar to the values obtained in healthy young male subjects when calculating OGI from arteriovenous differences (5.7 Ϯ 0.9 vs. 5.8 Ϯ 0.9) (45), which may be considered a more direct and precise measure of OGI, and thus supports true large interindividual differences in the oxygen-to-glucose consumption ratio in the resting brain.
The analysis also shows large regional variability of rCBF/ rCMR glc ratios with increased values in particular in infratentorial structures and in mesial temporal cortex compared with neocortex, and smaller variations in neocortical structures. Similar findings have been reported previously using normalized parameter maps (16) and absolute quantitative maps of rCMR glc and rCBF (47) . Such variable rCBF/rCMR glc ratio could logically reflect regional differences in either OGI or in OEF.
Increased OGI in infratentorial structures has previously been reported in an early PET study (48) and in a more recent study Vashniavi et al. (50) reported higher OGI in the cerebel- Including all measurements, a highly significant association is found (Spearman's r ϭ 0.56 and P Ͻ 0.001). The apparently nonlinear association is related to regions with higher rCBF/rCMRglc ratios (hollow symbols, i.e., thalami, mesial temporal and infratentorial structures) than white matter and neocortex (filled symbols). Striate shows similar slightly skewed distribution as neocortex. PET, positron emission tomography; rCBF, regional cerebral blood flow; rCMRglc, regional cerebral metabolic rate of glucose (not adjusted for regional lumped constant). Mean values are calculated as the mean of VOI values within each main region. †Adjusted for 12.4% lower lumped constant than whole brain. P values are derived from linear mixed models including only region as fixed effect and using neocortex as reference. For rCBF/CMRglc and rDO2/rCMRglc ratios significance testing was performed on log-transformed value. rCBF, regional cerebral blood flow; rCMRglc, regional cerebral metabolic rate of glucose; rDO2, regional oxygen delivery. lum and medial temporal cortex, and lower OGI in the prefrontal and parietal cortices. The possibility of regional differences in aerobic glycolysis, possibly reflecting persistence of gene expression typical of infancy associated with synapse formation and development growth (14) , has been addressed in two recent reports analyzing the same data set and yielding somewhat conflicting results. Hyder et al. (22) concluded that OGI is relatively uniform across the cerebral hemispheres, but did not include the cerebellum, whereas Blazey et al. (5) demonstrated significant regional differences in OGI in agreement with the initial report of Vaishnavi et al. (50) .
The distribution of increased OGI in the study of Vaishnavi et al. is similar to that of increased rCBF/rCMR glc found in in the present study, but as information of regional OEF was not available, it is not possible to calculate OGI regionally in the present data. Except from increased OEF in visual cortex (43) and reduced OEF in sensory-motor cortex (24) , uniform OEF is in the cerebral hemispheres has been argued to constitute a characteristic of the resting brain (43) . In particular, reports of cerebellar OEF (25, 30) do not support lower cerebellar OEF which otherwise could explain higher rCBF/rCMR glc . From the mean values reported in the present study, an average OGI in neocortex of 5.4 and in infratentorial structures of 7.1 can be estimated assuming similar OEF. Similar findings were made by Blazey et al. (5) .
Variations in OGI (and rCBF/rCMRglc ratio) could alternatively reflect utilization of substrates other than glucose. Lactate (6) and ketone bodies (10) may act as alternative energy substrates also in normal physiological conditions, but as these parameters were not measured we cannot make inferences about their possible role.
Also methodological factors may contribute to the observed lack of associations observed between gCBF, gCMR glc , and CMR O 2 . Method bias, imprecision, or inaccuracy may bias the analysis, in particular if the true variability in the population studied is low.
For quantification of rCBF and rCMR glc we applied standard PET techniques with full kinetic modeling, often considered reference techniques for quantification of these measures, and the measured values are within the expected range from studies using similar techniques (9, 42) . Regional or interindividual variation in arterial blood volume could bias the rCBF estimates (26) . To avoid this potential error, we applied a 1-tissue, 2-compartment model, which corrects for arterial blood volume and to some extent for the capillary blood volume (11, 38) . The residual capillary blood volume activity will have tissue values, and, thus, not change rCBF (38) . Tissue heterogeneity with variable white matter contribution in each VOI could potentially influence the regional differences in rCBF/ rCMR glc ratios depending on the white matter contribution, in particular in neocortical structures, but we find that a minor difference between white and gray matter rCBF/rCMR glc ratios is not a likely explanation for the larger differences between major brain regions in Table 3 .
The mean global CMR glc was lower than the typical textbook value of ϳ30 mol·100 g Ϫ1 ·min Ϫ1 , but similar to the value of 20.9 mol·100 g Ϫ1 ·min Ϫ1 reported in the reference for the lumped constant used for calculating CMR glc (55) . A 3-parameter model was applied for quantification of rCMR glc using a fixed lumped constant of 0.65. As rCMR glc is scaled to the ratio of the net uptake rate of FDG and the lumped constant, any error in the lumped constant will transfer directly to the calculated rCMR glc . Adjusting for a lower lumped constant in infratentorial structures (15, 48) to some extent attenuated the regional variations in CBF/CMRglc, but the difference between supra-and infratentorial structures remained highly significant. Also, estimates of global lumped constant indicate relatively large variability of the calculated lumped constant among healthy subjects (15, 17) , and it is possible that interindividual differences in lumped constant may contribute to the apparent interindividual lack of correlation of gCBF and gCMR glc .
We applied MRI susceptometry based oximetry for determination of venous oxygenation. The mean venous saturation in the present study of 67% is somewhat higher than the mean values of 57-64% obtained by jugular vein catheterization (8) . The resulting mean gOEF of 0.32 is consequently slightly lower than catheterization based mean values (range 0.35-0.42), and also lower compared with mean values estimated from PET (range of 0.40 -0.44) (1, 9, 27, 43) . To our knowl- Table 4 . Influence of brain region, glucose metabolism and oxygen extraction fraction on regional blood flow and oxygen delivery PET-rCBF, ml·100 g Ϫ1 ·min Ϫ1
PET-rDO2, mol·100 g Ϫ1 ·min Ϫ1 Results of linear mixed model analysis with either rCBF or rDO2 as dependent variable and main brain region, ⌬rCMRglc, gCMRglc, gOEF and as fixed effects. The categorical region effect estimates denote the difference in each region from the reference region (neocortex), whereas for the continuous parameters the estimate refers to the change in the dependent variable per unit change in the explanatory variable. †Estimate from separate model with infratentorial lumped constant 12.4% lower than supratentorial lumped constant.rCBF, regional cerebral blood flow; rDO2, regional oxygen delivery; gCMRglc, global cerebral metabolic rate of glucose; ⌬rCMRglc, regional deviation from gCMRglc; gOEF, global oxygen extraction fraction. edge, none of the currently available MRI methods for sagittal sinus oximetry have been tested against invasive measurements of venous blood leaving the brain in humans, but the technique used in present study has been validated in computer models (33) and anatomical phantom models (29) . Using this and similar MRI oximetry techniques, relevant changes in venous oxygenation in response to acute hypoxia (52), hypercapnia (28) , and apneic challenges (46) have been demonstrated. MRI oximetry thus appears to be the best available noninvasive alternative to catheterization for cerebral venous oxygenation measurements.
Measurement error (imprecision) in the explanatory variable will lower the regression coefficient due to attenuation bias. Analyzing measurements from both study days and adjusting for study day and intervention, we estimated the test-retest variability and thereby the expected attenuation factors for gCBF (intrasession) and gCMR glc (intersession), and MRI measurement of gCMR O 2 (intersession) to 0.816, 0.529, and 0.500, respectively. Consequently, the effect of gCMR glc or gCMR O 2 on gCBF will be ϳ50% lower than the true effect. If the variability of measurements is low relative to method precision it will be difficult to detect correlations. To address this concern we performed a post hoc power calculation showing that the study had a power of 0.88 for detecting a significant (2-sided P Յ 0.05) true correlation of 0.9 (r 2 ϭ 0.81) between gCBF and gCMR glc . We believe that the study had sufficient power to detect highly correlated measurements, but we cannot rule out that the study was underpowered for demonstrating less close inter-individual correlations, and including a larger study sample would have altered these findings. Nevertheless, the sample size of the present study is very typical or larger than neuroimaging studies involving quantitative PET techniques are in general. Whether the lack of correlations is due to imprecision or true lack of correlation, the findings indicate that quantitative CBF is a poor measure of interindividual differences in cerebral oxygen and glucose metabolism.
In addition to the limitations of the techniques applied, the study has some limitations related to the study design. First of all, measurements of rCBF, rCMR glc , and gOEF were performed sequentially and not simultaneously. Accordingly, variations in physiological state over the duration of the experiment could contribute to apparent dissociation of the measured parameters. By performing the experiment using a hybrid PET/MR system, simultaneous measurements can be obtained (3, 54) . Second, as pointed out above, we measured only gOEF and regional variations in OEF could therefore not be accounted for in the analysis, nor did we assess cerebral lactate production. Finally, we included only healthy young male volunteers in whom relatively low variability of the measured parameters may be expected. It is likely that selecting a population with larger biological variability, e.g., including elderly or diseased subjects, would have increased the possibility to detect an interindividual association of CBF with metabolism. However, one of the main aims of the analysis was to investigate whether the large interindividual variability in CBF reflected similar variability in brain metabolism in a typical research population of healthy volunteers. Using best available imaging techniques we could not confirm any such correlations, despite large and typical interindividual variabil-ity of the measured parameters. We believe that this is an important observation relevant when interpreting cross-sectional studies involving CBF measurements in healthy subjects.
In conclusion, using method-independent techniques, the present study demonstrated that quantitative perfusion is not a valid measure of cerebral glucose or oxygen metabolism, and further supports the possibility of regionally variable relationship between perfusion and glucose metabolism in the resting brain.
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